Literature DB >> 28506568

Adverse pathologic features in early oral squamous cell carcinoma and the role of postoperative radiotherapy-a review.

Narayana Subramaniam1, Deepak Balasubramanian2, Samskruthi Murthy1, Shashikant Limbachiya1, Krishnakumar Thankappan3, Subramania Iyer4.   

Abstract

The use of postoperative radiotherapy (PORT) in early stage oral cancer with adverse pathologic features (APFs) is controversial. Prognostically relevant APFs reviewed were perineural invasion, lymphovascular invasion, depth of invasion, worst pattern of invasion, and margin status. The current literature remains divided with regard to the benefit of treatment escalation in these patients; although these patients are at high risk for recurrence, the morbidity of PORT needs to be balanced against the likely benefit in disease control. A wide heterogeneity in the literature exists, likely as a result of differences in treatment protocols. We performed a literature review of the role of PORT in early-stage oral cancer with APFs. Based on the current evidence, the decision to administer adjuvant therapy needs to be made on an individual basis; patients with >1 APF are likely to benefit from PORT, and the use of risk-scoring systems may help in decision making.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28506568     DOI: 10.1016/j.oooo.2017.03.002

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  5 in total

Review 1.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue.

Authors:  Susan Muller; Wanninayake M Tilakaratne
Journal:  Head Neck Pathol       Date:  2022-03-21

2.  Risk Stratification in Oral Cancer: A Novel Approach.

Authors:  Irene Wen-Hui Tu; Nicholas Brian Shannon; Krishnakumar Thankappan; Deepak Balasubramanian; Vijay Pillai; Vivek Shetty; Vidyabhushan Rangappa; Naveen Hedne Chandrasekhar; Vikram Kekatpure; Moni Abraham Kuriakose; Arvind Krishnamurthy; Arun Mitra; Arun Pattatheyil; Prateek Jain; Subramania Iyer; Narayana Subramaniam; N Gopalakrishna Iyer
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

3.  Prognostic Impact of Adverse Pathologic Features in Sinonasal Squamous Cell Carcinoma.

Authors:  Anuraag S Parikh; Jennifer C Fuller; Ashton E Lehmann; Neerav Goyal; Stacey T Gray; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2020-05-19

4.  Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.

Authors:  Danielle N Margalit; Assuntina G Sacco; Jay S Cooper; John A Ridge; Richard L Bakst; Beth M Beadle; Jonathan J Beitler; Steven S Chang; Allen M Chen; Tom J Galloway; Shlomo A Koyfman; Carol Mita; Jared R Robbins; C Jillian Tsai; Minh T Truong; Sue S Yom; Farzan Siddiqui
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

5.  Multi-Site Tumour Sampling Improves the Detection of Intra-Tumour Heterogeneity in Oral and Oropharyngeal Squamous Cell Carcinoma.

Authors:  Weiping Jie; Jiaying Bai; Jing Yan; Yanting Chi; Bin-Bin Li
Journal:  Front Med (Lausanne)       Date:  2021-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.